Update on Liver Lesions: What Works in Managing HCC

Based on clear metrics, transplant hepatologist Neil Mehta, MD, presents diagnostic criteria for hepatocellular carcinoma, then shows how UCSF’s HCC team reaches decisions on treatment for individual cases – with plans ranging from resection or ablation to downstaging drugs and transplantation. Learn why UCSF is doing more transplants than ever for this most common form of liver cancer.  



November 9, 2020

Created by

UCSF MedConnection

Related Presenters

Neil Mehta, MD

Neil Mehta, MD


Dr. Neil Mehta is a gastroenterologist and specialist in liver transplantation. In his research, Mehta examines liver cancer treatment, particularly as related to liver transplants. He has contributed to important publications in this ...

View Profile